Key result
Advancements in seven key areas, including genomic medicine, artificial intelligence, tissue engineering, and mechanical circulatory support, are essential to further advancing the science and practice of pediatric cardiac critical care.
Why the study?
Exponential advances in science and technology are occurring rapidly, and applying them to pediatric cardiac critical care is essential to further advancing the field.
This review highlights emerging technologies and methodologies expected to shape the future of pediatric cardiac critical care.
Does not support immediate practice changes in pediatric cardiac critical care; leaves open validation of advances in genomic medicine, AI, and related fields.
Pediatric Cardiac Critical Care (PCCC) is a challenging discipline where decisions require a high degree of preparation and clinical expertise. In the modern era, outcomes of neonates and children with congenital heart defects have dramatically improved, largely by transformative technologies and an expanding collection of pharmacotherapies. Exponential advances in science and technology are occurring at a breathtaking rate, and applying these advances to the PCCC patient is essential to further advancing the science and practice of the field. In this article, we identified and elaborate on seven key elements within the PCCC that will pave the way for the future.
No takes yet. Share an insight, caveat, or question.
Pollak et al. (2022) conducted a review in Congenital heart disease. Advancements in seven key areas, including genomic medicine, artificial intelligence, tissue engineering, and mechanical circulatory support, are essential to further advancing the science and practice of pediatric cardiac critical care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: